SIP
EPZM

Stoneridge Investment Partners’s Epizyme, Inc EPZM Stock Holding History

Stoneridge Investment Partners’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-52,625
Closed -$677K – 316
2015
Q3 		$677K Sell
52,625
-15,162
-22% -$306K 0.1% 187
2015
Q2 		$1.63M Sell
67,787
-21,353
-24% -$411K 0.2% 134
2015
Q1 		$1.67M Buy
+89,140
New +$1.84M 0.2% 149

Other funds holding EPZM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Stoneridge Investment Partners's EPZM Position: Q4 2015 in Review

Stoneridge Investment Partners sold out of Epizyme, Inc (EPZM) in Q4 2015, closing a stake of 52,625 shares — an estimated $677K sold.

Stoneridge Investment Partners first reported a position in EPZM in Q1 2015 and held it in 3 quarters. The position peaked at $1.67M in Q1 2015. 89 funds tracked by Wall St. Rank hold EPZM as of Q4 2015.

  • Stoneridge Investment Partners reported no remaining Epizyme, Inc position as of Q4 2015 after selling out during the quarter.
  • Stoneridge Investment Partners sold 52,625 Epizyme, Inc shares in Q4 2015, an estimated $677K.
  • Stoneridge Investment Partners first reported a position in Epizyme, Inc in Q1 2015 and held it in 3 quarters.
  • Stoneridge Investment Partners's Epizyme, Inc position peaked at $1.67M in Q1 2015.
  • 89 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2015.

Based on Stoneridge Investment Partners's 13F filing for Q4 2015, filed 4 Feb 2016.